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0022-2836/$ - see front matter © 2007 EThe major allergen Der p 1 of the house dust mite Dermatophagoides
pteronyssinus is a papain-like cysteine protease (CA1) produced as an
inactive precursor and associated with allergic diseases. The propeptide of
Der p 1 exhibits a specific fold that makes it unique in the CA1 propeptide
family. In this study, we investigated the activation steps involved in the
maturation of the recombinant protease Der p 1 expressed in Pichia pastoris
and the interaction of the full-length and truncated soluble propeptides with
their parent enzyme in terms of activity inhibition and BIAcore interaction
analysis. According to our results, the activation of protease Der p 1 is a
multistep mechanism that is characterized by at least two intermediates.
The propeptide strongly inhibits unglycosylated and glycosylated recom-
binant Der p 1 (KD=7 nM) at neutral pH. This inhibition is pH dependent. It
decreases from pH 7 to pH 4 and can be related to conformational changes
of the propeptide characterized by an increase of its flexibility and
formation of a molten globule state. Our results indicate that activation of
the zymogen at pH 4 is a compromise between activity preservation and
propeptide unfolding.
© 2007 Elsevier Ltd. All rights reserved.Keywords: allergy; cysteine protease; inhibition mechanism; propeptide;
pH unfoldingEdited by F. SchmidIntroduction
House dust mite allergens are commonly asso-
ciated with allergic diseases such as asthma, peren-
nial rhinitis and atopic dermatitis. Der p 1 is a major
allergen from Dermatophagoides pteronyssinus as
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d type.
lsevier Ltd. All rights reservepopulation produce large amounts of Der p 1
specific IgE antibodies.1,2 It is a 25-kDa cysteine
protease belonging to the papain-like protease
family (CA1), which includes cathepsins K, L and
B. Like most secreted cysteine proteases, Der p 1 is
synthesized as a 34-kDa inactive precursor called
ProDer p 1, consisting of a cysteine protease domain
(222 residues) and an N-terminal propeptide (80
residues) that blocks the proteolytic activity. Each
domain contains one potential N-glycosylation
site in position 16p for the propeptide and in
position 52 for Der p 1.3,4 The propeptide might
also function as an intramolecular chaperone that
ensures correct folding and targeting of the enzyme
through the secretory pathway.
The proteolytic activity of Der p 1 has been
reported to be an additional factor for the allergicd.
171pH Dependence of Der p 1 Propeptide Inhibitionpathogenesis.5 Several reports indicated that Der p 1
is able to increase bronchial permeability by disrup-
tion of the intercellular tight junctions and cleavage
of the α1-antitrypsin serine protease inhibitor.6,7
Furthermore, Der p 1 is capable of cleaving receptors,
including the IgE low-affinity receptor (CD23)
present at the surface of plasmocyte cells, the
α-subunit of the interleukin-2 receptor (CD25) of T
cells and the CD40 of dendritic cells.5,8–11 All these
processes favor the development of the allergic
response; thus, the development of specific Der p 1
inhibitors is of considerable interest.
Furthermore, the comprehension of the ProDer p 1
activation process is of considerable interest in the
development of efficient recombinant mature aller-
gen production systems thus essential for the
screening of hypoallergenic vaccines.
Like most cysteine proteases, ProDer p 1 is
activated under low pH conditions.12–14 Despite
several attempts, in vitro demonstration of the
activation of ProDer p 1 remains partly unsuccess-
ful. For example, purified recombinant proforms of
Der p 1 expressed in mammalian CHO and insect
Drosophila cells could be converted into mature
forms by incubation at pH 4 but do not exhibit
enzymatic activity.15,16 More recently, however,
several groups have succeeded in converting ProDer
p 1 expressed in Pichia pastoris into mature enzyma-
tically active forms with IgE reactivity.13,14 Finally,
several experiments performed with ProDer p 1
mutants lacking the N-glycosylation sites or with
endoglycosylase H-pretreated ProDer p 1 indicated
that the glycosylation of recombinant zymogen
expressed in P. pastoris can impair the maturation
of the allergen.17,18
Analysis of the X-ray structure of the zymogen
form of the allergen reveals that the propeptide of
Der p 1 adopts a new fold within the CA1 protease
family19 (Fig. 1). This fold is characterized by the
presence of an N-terminal globular domain formed
by the association of three amphiphatic α-helicesFig. 1. Schematic representation of the different forms of th
identified during zymogen maturation. (a) Overall structure o
folding (1XKG). The propeptide is shown in black, whereas t
Sequence of the full-length Der p 1 propeptide. The numberin
corresponds to the N-terminal amino acid of the mature Der p
cleavage sites of the propeptide during the maturation of the N
grey. The position (16p) of the potential N-glycosylation site of
sequences of the His tag recombinant forms of the complete,maintained together by aromatic and hydrogen
bond interactions. This domain, despite tertiary
structure similarities, shows little or no conservation
of the consensus residues characteristic of the
cathepsin L-like propeptide subfamily.20 Moreover,
the presence of a fourth α-helix instead of a long
terminal coil and a β-sheet at the C-terminal
extremity make it unique among the previously
described CA1 propeptides. Based on Karrer et al.'s
classification, the Der p 1 propeptide could not be
assigned to the cathepsins L and B subfamilies.20
Meno et al. proposed that the Der p 1 propeptide
belongs to a third subfamily characterized by a
shorter propeptide with four α-helices and the
absence of β-strands.19 Therefore, the study of the
ProDer p 1 activation mechanism could represent an
interesting way to highlight the importance of the
presence or absence of a conserved propeptide motif
and secondary structure elements during the activa-
tion of the papain-like precursor.
In the last decade, the potent inhibitor ability of
several propeptides toward their corresponding
enzyme of the papain-like family has been exten-
sively studied.21–24 Some cathepsin propeptides
have been shown to display a strong inhibition
capacity at neutral pH, with values of the dissocia-
tion constant KD ranging from 0.12 nM for cathe-
psins L and B to 7.6 nM for cathepsins S and K.
Interactions between the propeptides and the
proteases are pH dependent: At neutral pH, slow
binding interactions occur, whereas at acidic pH,
weak or no interactions are observed.21 For the
cathepsin L propeptide, lack of inhibition has been
associated with partial unfolding of the propeptide
and formation of a molten globule state under acidic
conditions.25 Moreover, under these conditions, it
has been demonstrated that the cathepsin S propep-
tide is slowly degraded by mature cathepsin L.21
To date, the interaction between mature Der p 1
and its propeptide has not been investigated due
to the difficulty of obtaining correctly maturede Der p 1 propeptide and the location of the cleavage sites
f the ProDer p 1 zymogen showing the unique propeptide
he structure of the mature protease is shown in grey. (b1)
g of the propeptide is labeled with the letter p. Position 1
1. Arrows a, b, c and d indicate the positions of the different
52Q ProDer p 1 at pH 4. The α-helices are highlighted in
the propeptide is indicated by an asterisk. (b2) Amino acid
C-truncated and N-truncated propeptides.
172 pH Dependence of Der p 1 Propeptide Inhibitionrecombinant Der p 1 (rDer p 1). In order to char-
acterize this interaction, we studied the activation
steps involved in the zymogen maturation mechan-
ism. Furthermore, we produced different recombi-
nant forms of the Der p 1 propeptide (Fig. 1) and
analyzed their interactions with mature glycosy-
lated and unglycosylated rDer p 1 at different pH
values in terms of activity inhibition and structural
changes.Results
Production and maturation of purified ProDer
p 1 mutants
ProDer p 1 mutants encoding gene were con-
structed by overlapping PCR from the full-length
ProDer p 1 synthetic cDNA with optimized
mammalian codon usage.15 In these constructions,
the potential N-glycosylation sites in the propeptide
(N16p) and/or in the protease domain (N52) were
eliminated by substitution of asparagine by gluta-
mine (N16pQ, N52Q). Wild-type (WT) ProDer p 1
and the three mutants were successfully secreted by
P. pastoris. Figure 2a indicates that the substitution of
N16pQ in the ProDer p 1 yielded a mature glyco-
sylated rDer p 1. Therefore, the hyperglycosylation
site of the zymogen is the N52. This conclusion is
supported by the fact that the rDer p 1 obtained by
activation of ProDer p 1 N52Q or N16pQ/N52Q
mutants is unglycosylated (Fig. 2a). However,
surprisingly, for the N16pQ and N16pQ/N52Q
mutants, partial activation occurred during the
production, leading to the appearance of differentFig. 2. Mutants glycosylation pattern and time-dependen
Influence of glycosylation on the electrophoretic behavior of
molecular mass marker (Fermentas). Lane 2 represents glyco
glycosylated rDer p 1 yielded by the activation of N16pQ recom
p 1 yielded by glycosylated N52Q recombinant ProDer p 1
unglycosylated N16pQ/N52Q recombinant ProDer p 1. The d
mutants) migrates faster and as sharper bands due to the abse
of the different intermediates generated during ProDer p 1 ac
polybuffer 50 mM (pH 4) with (right panel) or without (left pan
SDS-PAGE (Coomassie Blue staining). Lanes 1 and 6 represent
7 represent purified N52Q (i.e., time 0). Lanes 3 and 8 represe
Lanes 5 and 10 represent 24-h incubation. The N-terminal s
AETNA/TNA, respectively.forms. The N-terminal sequencing of the purified
mutants revealed the presence of at least three forms,
previously described by Takai et al. and Jacquet et
al.13,14 The first one displayed the ATFE sequence,
which corresponds to the cleavage of the peptide
bond between Tyr19p and Ala20p. This site is only
three residues away from the propeptide N-
glycosylation site and gives rise to the loss of the
first α-helix of the propeptide (Fig. 1, site a). The
two other forms showed the AETN and TNA
sequences, which correspond to the mature allergen
form with and without a two-residue extension,
respectively. The ATFE intermediate could readily
be converted into the mature allergen after incuba-
tion at pH 4. Such cleavages within the propeptide
could not be observed for the WT proform
produced under the same conditions, confirming
previous observations that glycosylation of the
propeptide might decrease the maturation ability
of ProDer p 1.18
With the ProDer p 1N52Qmutant, four bands (Fig.
2b, lanes 2 and 7) were observed at the end of the
purification. In order to determine whether these
bands correspond to partially activated ProDer p 1 or
to a heterogeneous glycosylation at the N16p site, as
proposed by Takai et al., the proteins corresponding
to the major bands (A and B) were analyzed by N-
terminal sequencing.18 This revealed the presence of
the complete proform (RPSS, band A) and the ATFE
intermediate (band B). The N52Q mutant protein
was submitted to the maturation assay under acidic
conditions in both the presence and absence of 1 mM
DTT and 1 mM ethylenediaminetetraacetic acid
(EDTA) (Fig. 2b). Upon incubation in acidic buffer,
an increase in the intensity of band C, with an
apparent molecular mass of 27 kDa, was observed.t processing of ProDer p 1 N52Q zymogen at pH 4. (a)
ProDer p 1 and Der p 1. Lane 1 represents the 10-kDa
sylated WT recombinant ProDer p 1. Lane 3 represents
binant ProDer p 1. Lane 4 represents unglycosylated rDer
. Lane 5 represents unglycosylated rDer p 1 yielded by
ata clearly show that the unglycosylated rDer p 1 (N52Q
nce of hyperglycosylation at the N52 site. (b) Identification
tivation. Purified N52Q mutant was incubated at 25 °C in
el) 1 mMDTTand 1mMEDTA. Samples were analyzed by
10-kDa molecular mass markers (Fermentas). Lanes 2 and
nt 2-h incubation. Lanes 4 and 9 represent 8-h incubation.
equences of A, B, C and D are RPSS, ATFE, SNGG and
173pH Dependence of Der p 1 Propeptide InhibitionN-terminal sequencing of band C revealed the
occurrence of one additional intermediate species
characterized by the SNGG sequence, which corre-
sponds to the cleavage of the peptide bond between
residuesGln40p and Ser41p of the propeptide (Fig. 1,
site b). The evolution of the band intensities observed
in the absence of DTT and EDTA (Fig. 2b) clearly
indicates that this form appears after the ATFE
intermediate. Finally, after 24 h of incubation, formC
evolved in the mature form of Der p 1 (band D).
These results seem to confirm that ProDer p 1
maturation is a multistep mechanism that leads to
the formation of at least two intermediates. This
process could be accelerated in the presence of DTT
and EDTA (Fig. 2b), suggesting that the catalytic
cysteinemay play amajor role in the activation of the
zymogen.
Production and purification of the full-length and
truncated propeptides
The ProDer p 1 His-tagged full-length (Arg1p-
Glu80p), N-truncated (Tyr19p-Glu80p) and C-trun-
cated (Arg1p-Arg60p) propeptides were produced
in Escherichia coli as cytoplasmic soluble proteins.
About 90 mg of purified proteins per liter of culture
were obtained for the three propeptide forms.
N-terminal sequencing of the three propeptides re-
vealed the MHHH sequence, confirming the pre-
sence of the His-tag preceded by the N-terminal
methionine. The molecular mass of the full-length
form was determined by mass spectrometry, which
gave a value of 10,227 Da, perfectly matching the
value calculated from the amino acid sequence
(10,227.3 Da).
Activity inhibition and pH dependence
Our kinetic experiments indicated that the full-
length propeptide inhibits the proteolytic activities
of unglycosylated (N52Q) and glycosylated rDer pFig. 3. Inhibition of rDer p 1 by its propeptide. Measuremen
Time-dependent inactivation of rDer p 1 (5 nM) by propeptide
was 160 μM. Each curve was obtained in triplicate. (b) Plot of
determined for the glycosylated (○) and unglycosylated (N521, with dissociation constant values (KDGlobal) of
7 ±1 nM (koff = 0.008 ± 0.001 s
− 1) and 9±4 nM
(koff=0.008±0.003 s
−1) at pH 7, respectively. Pro-
gress curves of product formation in the presence of
increasing concentrations of unglycosylated propep-
tide (from 0 to 120 nM) are shown in Fig. 3a. These
data highlight the slow binding interaction between
the propeptide and rDer p 1 and allow calculation of
the value of the pseudo first-order rate constant, kobs,
at various propeptide concentrations. KD values
were computed based on model 1 using Eq. (4) (Fig.
3b). With both glycosylated and unglycosylated
rDer p 1, identical KD values within the error limit
were obtained, indicating that glycosylation of the
protease domain does not impair the propeptide
association. This observation can be explained on
the basis of the position of the N52 glycosylation
site, which, in the structure of the zymogen, is
situated on the opposite side of the enzyme active
site and therefore cannot interact with the propep-
tide during association. Interestingly, no significant
inhibition could be detected with truncated propep-
tides (data not shown). At the highest concentration
tested (5 μM), only a minor decrease (≤10%) of
the initial activity could be monitored with the
N-truncated propeptide, whereas no change was
detected with the C-truncated form. These observa-
tions show the importance of the C- and N-terminal
domains of the propeptide for the inhibition process.
The activity of rDer p 1 and its interaction with the
propeptide were shown to be pH dependent. The
initial rates of product formation measured at
different pH values are shown in Fig. 4a. rDer p 1
is active at pH values ranging from 3.5 to 9, with
maximal activity at approximately pH 6.5. At pH 4,
rDer p 1 retains 15% of its maximal activity, which
can be sufficient to ensure zymogen activation. Our
results are in good agreement with the pH activity
profile established by Schulz et al.26
A comparison of the steady-state rates of product
formation measured at different pH values, in thets were performed at 25 °C in 50 mM polybuffer (pH 7). (a)
(30–100 nM). The concentration of Boc-Gln-Ala-Arg-AMC
kobs versus propeptide concentration. The kobs values were
Q) (•) rDer p 1. Average values are given with the SD.
Fig. 4. pH dependence of the interaction between Der p 1 and its propeptide. Measurements were performed at 25 °C
in 50 mM polybuffer between pH 3 and pH 9. (a) The activity of N52Q rDer p 1 (5 nM) at different pH levels and in the
presence of propeptide (0 to 80 nM) was measured at the steady state of the hydrolysis rate of 40 μM Boc-Gln-Ala-Arg-
AMC. Each experiment was done in triplicate. Average values are given with the SD. (b) Dependence of the residual
activity (%) of rDer p 1 in the presence of different propeptide concentrations.
174 pH Dependence of Der p 1 Propeptide Inhibitionpresence of increasing propeptide concentrations,
highlights the pH dependence of the inhibition
process (Fig. 4a and b). At pH 4, the enzyme remains
fully active even in the presence of high propeptide
concentrations, whereas in the pH range 6–7, less
than 20% of the enzyme activity is retained at a
propeptide concentration of 40 nM or higher.
Propeptide/Der p 1 association and dissociation
by surface plasmon resonance (SPR)
The affinity of the propeptide for rDer p 1 (N52Q)
was first evaluated using a competition assay in
solution, and a dissociation constant (KD) value of
12±2 nM could be determined (data not shown).
This value indicates that the full-length propeptide
displays a high affinity for Der p 1. In addition, a
kinetic analysis allowed calculation of the rate
constants for association (ka) and dissociation (kd).
A summary of the calculated rate and equilibrium
constants is shown in Table 1. A global analysis of
the association and dissociation data with several
models revealed that the data could not be fitted to a
simple 1:1 binding model (model 1) but are better






















−9) –conformational change (model 2), leading to the
formation of a higher affinity complex (Fig. 5a), or
by a heterogeneous ligandmodel (model 3) (Fig. 5b).
The former model implies a 1:1 binding of rDer p 1
to the immobilized propeptide, followed by a
conformational change of the complex, which can
affect the propeptide, rDer p 1 or even both. The
value of the global affinity constant obtained by
fitting the data to model 2 (KD=12.9±0.2 nM) is not
significantly different from the value obtained in
solution. Alternatively, the heterogeneous ligand
model yielded the KD values of 7.2 and 76 nM. Such
a model is often observed when the ligand has
multiple attachment sites to the sensor chip. Two of
the seven lysine residues, which participate to the
covalent immobilization of the propeptide, are
located in the C-terminal part of the propeptide.
Thus, the lower affinity constant value (76 nM)
could correspond to the propeptide molecule
immobilized through these two residues, in a less
accessible orientation for Der p 1. Even if these two
models reflect two phenomena, the calculated
constants for the two models are in the same order
of magnitude and are in good agreement with those












Fig. 5. Analysis by SPR spectroscopy of the binding of rDer p 1 to the full-length propeptide immobilized on a BIAcore
CM5 chip. Different concentrations (0, 15, 30, 60, 120 and 240 nM) of rDer p 1 N52Q in Hepes buffered saline were injected
at a flow rate of 70 μl/min. Kinetic rate constants (ka and kd) were fitted using: (a) the two-state reaction model including a
conformational change and (b) the heterogeneous ligand model. The lower panel corresponds to the residual value of the
fitting for each rDer p 1 concentration.
175pH Dependence of Der p 1 Propeptide InhibitionThe validity of the two-state model was also
analyzed by fitting the different rate constants
determined by SPR to the different experimental
product formation curves obtained at different
propeptide concentrations. Primary fitting and
optimization analysis of each time curve permitted
determination of different sets of optimal rate
constants for each initial propeptide concentration
higher than 50 nM. The different rate constantsFig. 6. Simulation of the evolution of the different compl
represents the evolution of the computed free enzyme [E] and
time. The right ordinate represents experimental product form
and the corresponding simulated fitting curve. Data were comp
propeptide concentration of 70 nM using the optimized rate con
the evolution of the initial rates versus initial propeptide conce
ratio of the maximal velocity over the calculated initial veloci
regression was performed using Grafit software.obtained from the primary analysis agreed fairly
well with the values determined by SPR. Based on
these data, the different sets of rate constants were
averaged and recomputed for all product formation
curves. The resulting optimized rate constants are
listed in Table 1. Computed values permitted
following the evolution of the concentration of the
different enzyme species during the reaction time
(Fig. 6a). Free enzyme concentration (E) decreasesex species during the reaction time. (a) The left ordinate
complexes of species ([EI] and [EI*]), concentration versus
ation curve measured in the presence of 70 nM propeptide
uted from the experimental points recorded with an initial
stants presented in Table 1. (b) The left ordinate represents
ntrations. The right ordinate represents the evolution of the
ties as a function of the propeptide concentrations. Linear
176 pH Dependence of Der p 1 Propeptide Inhibitionrapidly as a well-shaped exponential curve, whereas
the initial complex concentration (EI) increases in the
first quarter of the reaction time and then decreases
to reach about 55% of the [E0] at the end of the
reaction time. The final complex (EI*) appears
rapidly after EI, reflecting the rapid conversion of
the initial complex in the more stable EI* complex.
The final complex (EI*) concentration then increases
to reach the remaining 45% of the initial enzyme
concentration.
pH-Dependent conformational changes of the
propeptide
The shift in the propeptide inhibition profile from
pH 5.5 to pH 4 (Fig. 4b) could be explained by
conformational changes of the propeptide. The near-
UV circular dichroism (CD) spectrum of the
propeptide at neutral pH shows two maxima of
ellipticity at 278 and 286 nm, suggesting that at least
one of the three tyrosine residues present in the
N-terminal globular domain is in an asymmetric
environment (Fig. 7a). Comparison of the near-UV
CD spectra recorded from pH 7 to pH 2 reveals
minor changes in the tertiary structure organization
when pH shifts from 7 to 4, followed by a total loss
of the near-UV CD signal between pH 4 and pH 2.
On the other hand, far-UV CD measurements (Fig.
7b) indicate that the free propeptide is characterized
by a high α-helical content, which is in good
agreement with the analysis of the zymogen
structure (Fig. 1). The far-UV CD spectra recorded
at different pH values display no major change in
the secondary structure at a pH of 4 or higher,
whereas the spectra reveal a significant loss of the
secondary structure content at pH 3 and pH 2.
Changes in the near-UV CD spectra between pH 7
and pH 4 can be related to an increase in the intrinsic
fluorescence of the tyrosine located in the N-term-
inal part of the propeptide. Furthermore, the pH
dependence of the tyrosine fluorescence emissionFig. 7. Near- and far-UV CD spectra of full-length Der p 1
recorded at 25 °C in 10 mM polybuffer in the presence of 100 an
spectra, respectively. The inset shows the pH-induced unfo
contents followed at 278 and 222 nm, respectively.was recorded at 305 nm (Fig. 8a). A significant
increase in intensity is observed between pH 7 and
pH 4, which coincides with the gentle decrease in
CD signal observed at 278 nm. These changes in the
optical properties of the propeptide can be
explained by an increase in solvent accessibility of
at least one tyrosine residue, with maximum
exposure at pH 4 and a midpoint at pH 5.5. Taken
together, these data suggest that acidification of the
solution up to pH 4 leads to conformational changes
in the globular N-terminal domain of the propeptide
that are characterized by an increase in the solvent
accessibility of at least one tyrosine residue and the
conservation of a large part of the secondary and
tertiary structures. At pH values lower than pH 4,
the propeptide loses its tertiary and secondary
structures. These results were confirmed by the
study of the propeptide flexibility at different pH
values (Fig. 8b). The minor increase of the value of
the Stern–Volmer constant (KSV) observed between
pH 5 and pH 4 could be related to the conforma-
tional changes observed in CD and intrinsic fluor-
escence measurements, whereas the large increase of
the KSV value observed between pH 4 and pH 2 can
be ascribed to the loss of tertiary and secondary
structures observed in the near- and far-UV CD
experiments, respectively (Figs. 8 and 9). All these
data indicate that upon acidification to pH 4, the
propeptide is transformed into a molten globule-like
intermediate. Further evidence for the existence of
this intermediate was obtained by monitoring the
fluorescence of 8-anilino-1-naphthalenesulfonic acid
(ANS) in the presence of the propeptide at different
pH values. ANS fluorescence showed maximum
intensity at pH values between 3 and 4, confirming
the presence of a molten globule state under these
pH conditions (Fig. 8c).
Finally, we could show that under acidic condi-
tions (i.e., pH ∼4), rDer p 1 rapidly degrades its
propeptide into low-molecular-weight fragments
(Fig. 9). This proteolysis could be associated withpropeptide (100 μM) at different pH values. Spectra were
d 20 μMof full-length propeptide for near- and far-UV CD
lding transition of the tertiary and secondary structure
Fig. 8. Propeptide conformational changes followed by
fluorescence spectroscopy. (a) Evolution of tyrosine resi-
due intrinsic fluorescence recorded at 305 nm for full-
length (•) and C-truncated (○) propeptides as a function
of pH. Spectra were recorded at 25 °C in 50 mM poly-
buffer. The concentration of the propeptide was 5 μM. (b)
pH dependence of the acrylamide quenching constant KSV
values measured with the full-length (•) and C-truncated
(○) propeptides. Fluorescence quenching was recorded at
305 nm in 50 mM polybuffer. (c) Evolution of ANS
fluorescence recorded at 484 nm as a function of pH
for full-length (•) and N-truncated ( ) propeptides.
Spectra were recorded at 25 °C in 50 mM polybuffer.
Propeptide and ANS concentrations were 5 and 200 μM,
respectively.
Fig. 9. pH-dependent proteolysis of the full-length
propeptide by mature Der p 1. Time-dependent proteo-
lysis of the propeptide at pH 7 (a) and pH 4 in the absence
(b) or presence (c) of E-64. A total of 70 μg of propeptides
was incubated at 37 °C with 3 μg of mature N52Q rDer p 1
in 50 mM polybuffer containing 1 mM DTT and 1 mM
EDTA at pH 7 and pH 4 and then analyzed by SDS-PAGE
18%. Lane 1 represents the 10-kDA molecular mass
marker (Biorad, Hercules, USA). Lanes 2–8 correspond
to 0.5, 2, 5, 10, 15, 30 and 40-min incubation periods of the
propeptide in the presence of rDer p 1 N52Q.
177pH Dependence of Der p 1 Propeptide Inhibitionthe loss of the propeptide inhibition ability during
incubation at pH 4 because no hydrolysis could be
detected at pH values higher than 4.5. Similar
experiments performed with rDer p 1 treated with
E-64, a specific irreversible inhibitor of cysteine
proteases, did not lead to propeptide hydrolysis
even at pH 4, showing that the degradation of thepropeptide was due to the enzymatic activity of Der
p 1.
Molecular modeling
Two average conformations of the propeptide
were determined considering the time interval from
61.5 to 100 ps for the first one and from 601 to
1100 ps for the second. They were soaked in a 5-Å
layer of water molecules, and the geometries of the
whole systems were optimized. The two final
geometries of the propeptide were compared with
the starting one and superpositions were performed
by taking into account all the heavy atoms of the
propeptide (Fig. 10). It is clear that the major
conformational changes from the propeptide geo-
metry in the complex to its geometry as a free entity
were occurring before 100 ps in the simulation
because the two skeletons change much less in the
final geometry than in the intermediate geometry.
The geometry variation was the largest at the hinge
between the α2-helix and the α3-helix, which mainly
translates in a large change in two dihedral angles
(pi) defined by the Cα of four residues: residues 54,
53, 52 and 51 for p1 and residues 55, 54, 53 and 52 for
p2; p1 varies from −119 to −45 deg during the first
100 ps, whereas p2 changes from −110 to −155 deg.
The conformational changes result in the formation
of a hydrophobic cluster at the (α2–α3) hinge as
shown in Fig. 10. Furthermore, a significant change
at the hinge between the α3-helix and the α4-helix
also occurs after 100 ps.Discussion
Previous studies highlighted difficulties to cor-
rectly mature recombinant ProDer p 1 expressed in
Fig. 10. Hydrophobic clustering
of the hydrated free Der p 1 propep-
tide. (a) Initial geometry of the pro-
peptide from 1XKG, intermediate
geometry averaged on [51.5–100] ps
and final geometry averaged on
[601–1100] ps and then optimized.
Only the skeleton of the Cα is drawn.
(b) Detailed view of the (α2–α3)
hinge showing the main hydro-
phobic residues that tend to form
a cluster of the starting (left) and
optimized [51.5–100 ps] (right) geo-
metries. Red, Leu49p, Leu52p, Leu54p
and Leu62p; green, Tyr38p, Phe57p
and Phe61p.
178 pH Dependence of Der p 1 Propeptide Inhibitiondifferent hosts and suggested that the glycosylation
level of the zymogen ProDer p 1 could interfere with
the activation process.17,18 In this study, we inves-
tigated the influence of the different potential
N-glycosylation sites in the maturation process
and the pH influence on the propeptide association.
Identification and localization of the cleavage
sites in the activation of ProDer p 1
Elimination of the propeptide N-glycosylation
motif present in the ProDer p 1 led to partial
maturation of the corresponding zymogen during
the fermentation process. This maturation was not
observed for the WT ProDer p 1 expressed in the
same conditions. Moreover, ProDer f 1, a homo-
logous zymogen from Dermatophagoides farinae,
which only possesses one N-glycosylation motif in
its protease (N53) domain, is easily activated in
vitro.27 N-terminal sequencing of the bands obtained
at the end of the fermentation for the N16pQ/N52Q
ProDer p 1 mutant revealed the presence of a
multistep activation mechanism initiated by the
cleavage of the Tyr19p–Ala20p bond. The sequence
of the first intermediate (ATFE) showed that the
cleavage site is located in the solvent exposed coil
that connects the first two α-helices of the propep-
tide (Fig. 1). On the other hand, the far-UV CD
spectra of the full-length propeptide monitored at
pH 4 showed that the propeptide retained a large
part of its secondary structures at this pH value. This
observation, together with the location of the
cleavage site, indicated that the first cleavage
occurred in a solvent-exposed part of the propeptide
structure that does not possess a secondary structure
at pH 4. Moreover, the N-truncated propeptide was
unable to inhibit rDer p 1 even if present in a large
concentration suggesting that cleavage of the first
alpha helix could represent the limiting step of the
activation mechanism. However, we cannot excludethe possibility that this propeptide partially inhibits
the allergen activity when still anchored to the
enzyme. The fact that the formation of the ATFE
intermediate, which is only three residues away
from the propeptide N-glycosylation site, is the
limiting step could explain the absence of partial
activation observed for WT ProDer p 1. This
observation is in good agreement with that of
previous studies of the influence of glycosylation
on the activation process. This hypothesis could also
explain the different results reported by Jacquet et al.
and van Oort et al.16,17 van Oort et al. did not succeed
in obtaining maturation of WT recombinant ProDer
p 1 with the correct N terminus,17 whereas Jacquet et
al. reported that the WT ProDer p 1 lacking the first
19 residues was easily converted into mature
allergen after acidic treatment.16 However, the fact
that the ProDer p 1 N52Q mutant also presents the
ATFE intermediate at the end of the production may
be attributed to the heterogeneous glycosylation of
the propeptide as previously proposed.18 Therefore,
its presence could be attributed either to the partial
activation of the minor glycosylated form or to the
decrease of the steric hindrance corresponding to the
lack of glycosylation of site 52 in the hypothesis of
an intermolecular activation of the zymogen.
For the ProDer p 1 N52Q mutant, the maturation
led to the appearance of a newbandwith amolecular
mass intermediate between that of the ATFE form
and that of mature allergen. This intermediate is
characterized by the SNGG N-terminal sequence.
This motif is located at the end of the second α-helix
of the propeptide in a solvent-accessible area.
Furthermore, this intermediate could correspond to
the intermediate observed during the activation of
the ATFE intermediate obtained with WT ProDer p
1.14 These two cleavages occurred in regions that
correspond to sequences specifically recognized by
Der p 1. Indeed, recent studies demonstrated that
natural Der p 1 displays a predominant preference
179pH Dependence of Der p 1 Propeptide Inhibitionfor hydrophobic residues in position P2 and a slight
preference for basic and polar amino acid residues in
positions P1 and P3, respectively.26,28 Considering
this substrate specificity, the two cleavage sites
identified in the propeptide contained adequate
residues at the P3-P2-P1 positions (i.e., Lys17p-
Ser18p-Tyr19p and Tyr38p-Val39p-Gln40p), consis-
tent with the Der p 1 specificity. N-terminal sequen-
cing of the mature allergen forms indicated that
cleavages also occurred at the end of the propeptide
and generated the mature enzyme with a two-
residue extension or with the correct N terminus.
This phenomenon was also reported for other
cysteine proteases and has been observed for ProDer
p 1 maturation.12–14 These two cleavages occurred at
sequences Asp76p-Leu77p-Asn78p and Asn78p-
Ala79p-Glu80p and were in agreement with the
Der p 1 substrate specificity. In other papain-like
protease precursors, additional cleavages occurred
in a region located just after the second β-strand.12,29
The lack of such cleavages in ProDer p 1 activation
could be explained by the shorter length of the Der p
1 propeptide or by the presence of the fourth α-helix
that could decrease the proteolysis accessibility of
the corresponding area.
Propeptide inhibition
In this study, we investigated for the first time the
interaction between soluble unglycosylated Der p 1
propeptide and its recombinant parent enzyme in
terms of activity inhibition and SPR interaction
analysis. The propeptide inhibits unglycosylated
and glycosylated Der p 1 with KD values of 7 and
9 nM, respectively. These dissociation constant
values were confirmed using SPR technology. SPR
permits the study of the association and the
dissociation as two independent events that are
complementary to the enzymatic approach. Fitting
the SPR curves to different models allowed to show
that two models could describe the interaction
between rDer p 1 and its propeptide. From the
comparison of the kinetic rate constants obtained
from these two models and kinetic rate constants
obtained by enzymatic analysis (Table 1), we could
not exclude one of these two models. The dissocia-
tion constants determined by these two approaches
were lower than the dissociation constants observed
for the other papain-like propeptides but are similar
to the results obtained for cathepsins K and L
(KD≈2.6 nM) for which the propeptide shows a high
level of similarity with the Der p 1 propeptide.23,30
The presence of a two-step reaction mechanism had
been proposed to explain the association of propep-
tides with cathepsin L.30 This association could be
initiated by weak contacts between the enzyme and
the propeptide inducing conformational changes in
one or both partners, leading to a more stable
complex. Evidence of these conformational changes
in the case of rDer p 1 could be demonstrated by the
comparison of the initial and steady-state rates of
the enzyme in the presence of increasing concentra-
tions of the propeptide (Figs. 3a and 7b). Analysis ofthe first part of the product formation curves
showed an instantaneous decrease of the initial
velocity when propeptide concentration increased,
which indicated immediate inhibition and allowed
the determination of the dissociation constant of
36.7 nM for the first equilibrium (75 nM for SPR).
This transition complex was readily converted into a
more stable complex with global KD values of 7 nM
for enzymatic analysis and 12.9 nM for SPR analysis.
The presence of a two-state interaction model was
also analyzed and confirmed by fitting the experi-
mental inhibition curves. Computer analysis per-
mitted determination of the different rate constants
describing the experimental curves by a two-
equilibrium reaction model. Simulated values were
in good agreement with those determined by SPR
except for ka1 and kd1, which are slightly different.
This observation underlines the difficulty of com-
paring data recorded for the interaction between
free partners or with one of them immobilized at the
surface of a sensor chip. Analysis of the evolution of
the two-complex concentration during the reaction
time permitted to show the presence of initial and
final complexes in the early reaction time, which
could explain the difficulty of pointing out a two-
state model in our kinetic inhibition analysis. More-
over, detection of a two-state model by inhibition
analysis could be complicated by the presence of
both inhibited complexes related by a rapid conver-
sion rate (KDFinal=0.2).
As an illustration of the conformational changes
between the initial (EI) and final (EI*) complexes,
molecular modeling and dynamics showed that in
water, the free propeptide undergoes fast conform-
ational changes from its geometry in the complex
that are mainly characterized by a rotation of the
third and fourth α-helices in comparison with the
N-terminal globular domain (Fig. 10). This confor-
mational change could explain the observation of a
two-equilibrium interaction model. Indeed, interac-
tions could be initiated by loose contacts between
the hydrated free propeptide forming the initial
complex (EI) followed by a redocking of the fourth
α-helix in the active site cleft driven by dehydration
and the presence of a stereocomplementary charged
area and hydrophobic patches leading to the
formation of a more stable complex (EI*). In this
state, the propeptide could adopt a conformation
similar to that prevalent in the zymogen.
Free propeptide structure and pH unfolding
Previous studies of the interactions between
proteases and propeptides did not intensively
analyze the evolution of the structure of the free
propeptide during acidification. Studies of the pH
unfolding of the cathepsin L propeptide revealed
that it exhibited a high content of secondary
structures and a tertiary structure at neutral pH.
On the other hand, at pH 4, it lost a large part of its
tertiary structure but retained its secondary struc-
ture content.25 In these conditions, the obtained
propeptide intermediate was able to bind ANS. Our
180 pH Dependence of Der p 1 Propeptide Inhibitiondata showed that, as for the cathepsin L propeptide,
the Der p 1 propeptide and its C-truncated form
were folded as compact globular domains at neutral
pH. The ability of the free propeptide to adopt a
correct fold independently of the protease domain
demonstrates that this propeptide is a good can-
didate for acting as an intramolecular chaperone,
as reported for other cysteine protease propep-
tides.24,31 No tertiary structure was detected by
intrinsic fluorescence emission or by near-UV CD
spectra for the N-truncated propeptide. This absence
of a tertiary structure was due to the deletion of the
first α-helix, which seems to play a key role in the
folding of the propeptide.
Activation of the ProDer p 1 zymogen in the
mature allergen must likely occur when interactions
between the propeptide and the protease become
weaker. For cysteine protease zymogens, this con-
dition is reached by lowering the pH to 4.
Proteolysis of the zymogen propeptide generates
free propeptide or non-inhibitory propeptide frag-
ments. Cleavages can result from intramolecular or
intermolecular processes, depending on the zymo-
gen.12,29 In the present study, we showed that the
free propeptide of Der p 1 undergoes conforma-
tional changes under acidic conditions. At pH 4, this
conformational transition led to a minor decrease of
the tertiary structure but to a large increase in the
solvent accessibility and flexibility of the residues
located in the N-terminal globular domain. In this
state, the propeptide retains a high amount of
secondary structures and binds ANS. At lower pH,
we have shown that the propeptide loses its residual
tertiary and secondary structures and therefore its
ability to bind ANS. No ANS binding was detected
for the C-truncated propeptide, whereas increase in
the ANS fluorescence was detected with the N-
truncated form, suggesting that the C-terminal part
of the propeptide plays a major role in the formation
of the molten globule state. This may be due to the
presence of the long fourth amphiphatic α-helix. The
conformational changes recorded during acidifica-
tion can be correlated to the shift of the inhibitory
properties of the propeptide at acidic pH. Our re-
sults clearly show a relationship between the con-
formational changes recorded for the propeptide
when pH decreases from pH 7 to pH 4 with a
decrease of the interaction between the propeptide










Introduced restriction sites are in boldface.analysis. From these results, we can conclude that
zymogen activation occurs at pH values inducing
changes in the propeptide structure and permitting
sufficient activity of the mature protease to enhance
the activation process.
In conclusion, according to our results, the matu-
ration process of ProDer p 1 under acidic condi-
tions is a multistep process. In these conditions,
the solvent accessibility of the propeptide residues
increases and exposes the sequence specifically
recognized by Der p 1. A first cleavage between
Tyr19p and Ala20p of the propeptide liberates the
first α-helix and thus further decreases the inter-
action between the two partners. This decrease
results in rendering other parts of the propeptide,
such as the end of the second α-helix and the
C-terminal extremity of the propeptide, more
sensitive to proteolysis.Materials and Methods
Construction of the unglycosylated ProDer p 1
expression vectors
The N52Q, N16pQ and N16pQ/N52Q unglycosylated
ProDer p 1 mutants (Der p 1 numbering) were constructed
in two steps by overlapping PCR from pNIV4878.15 The
sequences of the primers used in this study are detailed in
Table 2. The amplified fragments were cloned into the
pCR2.1 TOPO cloning vector (Invitrogen, Groeningen,
The Netherlands), and the presence of both mutations of
interest was verified by DNA sequencing. The fragments
containing the ProDer p 1 coding sequence, isolated by
digestion of the recombinant pCR2.1 TOPO with StuI-
AvrII, were subsequently cloned into the pPIC9K expres-
sion vector (Invitrogen) previously restricted by SnaB1-
AvrII. The resulting expression vectors contain the ProDer
p 1 cassettes downstream of the Saccharomyces cerevisiae α-
factor.
Expression of the ProDer p 1 proforms in P. pastoris
The recombinant expression vectors were introduced
into P. pastoris SMD1168 (Invitrogen) using the electro-
poration transformation method. Transformants were first
selected for histidinol dehydrogenase (His+) and then for
increasing geneticin (G418) resistance (0.25 to 3 mg/ml).
Selected clones were grown at 30 °C in 200 ml of yeast









181pH Dependence of Der p 1 Propeptide InhibitionThis preculture was then transferred into 3.5 l of
fermentation minimal medium and cultured for 24 h at
30 °C (pH 6). Production of the recombinant ProDer p 1
was then induced by the addition of methanol over 4 days
(final concentration=0.5%). The methanol feed rate was
regulated by following the dissolved oxygen level (30%).
The supernatant was finally obtained by centrifugation of
the culture at 13,000g for 20 min.
Purification and maturation of the ProDer p 1
proforms
The yeast culture medium containing the recombinant
ProDer p 1 was dialyzed during 24 h against 20 mM Tris–
HCl buffer (pH 8.5, starting buffer). The mediumwas then
loaded onto a Q-HP Sepharose column (60 ml; Amersham
Biosciences, GE Healthcare, Uppsala, Sweden) equili-
brated with the starting buffer. The column was washed
with the same buffer and the bound proteins were eluted
with a linear NaCl gradient (0–0.3 M). The fractions
containing ProDer p 1 were pooled and concentrated by
ultrafiltration (cutoff=10 kDa). A homogeneous solution
of ProDer p 1 could be obtained by gel filtration on a
Sephacryl-100HR column (120 ml; Amersham Bios-
ciences) equilibrated in 10 mM Na2HPO4/KH2PO4 buffer
(pH 7.4) in the presence of 150 mM NaCl (phosphate
buffered saline [PBS]). The concentration of ProDer p 1
was estimated by bicinchoninic acid assay (Pierce, Rock-
ford, IL, USA).
ProDer p 1 maturation assay
The maturation was performed as previously des-
cribed,14 with the following modifications: the purified
ProDer p 1 was dialyzed against 100 mM acetate buffer at
pH 4 during 72 h at 4 °C.13,14 For the N52Q proform,
maturation was performed at 37 °C in polybuffer (mix of
50 mM Tris, phosphate, citrate, acetate and KCl, adjusted
to chosen pHwithHCl, pH 4), with orwithout the addition
of 1 mM DTT and 1 mM EDTA. The maturation was
followed by SDS-PAGE analysis, confirmed by N-terminal
sequencing and enzymatic activity measurements.
Construction of the full-length and truncated
propeptide expression vectors
The DNAs encoding to the full-length (Arg1p-Glu80p),
N-terminal (Tyr19p-Glu80p) and C-terminal (Arg1p-
Arg60p) truncated forms of the Der p 1 propeptide
together with an N-terminal sequence encoding for six
histidine residues (His-tag) were constructed by PCR
using pNIV4878 as the template.14 The primers used to
amplify the propeptide sequences were obtained from
Eurogentec (Seraing, Belgium) (Table 2). The PCR pro-
ducts were cloned into pGEM-T Easy (Promega, Madison,
WI, USA). The DNA fragments encoding the propeptide
were sequenced to verify the correct amplification and the
presence of the His tag. The propeptide coding cassettes
were digested with NdeI and EcoRI restriction enzymes
and cloned into pET-22b(+) (Novagen, Oxon, UK),
previously restricted with the same enzymes.Expression and purification of the propeptides
Recombinant expression vectors were transformed into
E. coli BL21 (DE3) pLys cells (Novagen). Transformantswere selected on Luria–Bertani agar plates containing
ampicillin (100 μg/ml) and chloramphenicol (30 μg/ml).
The expression was initiated by a (1/50) dilution of an
overnight subculture in 2 l of Luria–Bertani medium
containing ampicillin (100 μg/ml) and chloramphenicol
(30 μg/ml) until an A600 value between 0.5 and 1 was
reached. The propeptide expression was induced by the
addition of IPTG (Immunosource, Halle–Zoersel, Belgium)
to a final concentration of 1mM in themedium. After 6 h of
incubation at 28 °C, the cells were collected by centrifuga-
tion. The pellet was resuspended in PBS (pH 7.4) and then
lysed with the help of a disintegrator (Constant Systems,
Daventry, UK). The lysate was centrifuged for 20 min at
12,000g, and the pellet was discarded. The supernatantwas
applied onto a Ni-PDC column (10 ml; Affiland, Liège,
Belgium) equilibrated in PBS. The column was washed
with 10 volumes of PBS, and 5 volumes of the PBS 2 M
NaCl. The propeptide was eluted with a linear imidazole
(20–250 mM) gradient. The fractions enriched in the
propeptide were pooled and dialyzed against 20 mM
Tris buffer (pH 8). Further purification was achieved by
anion-exchange chromatography on a MonoQ column
(Amersham Biosciences) equilibrated with Tris buffer. The
elution was performed with a linear NaCl (0–600 mM)
gradient. Fractions containing the pure propeptide were
pooled and dialyzed overnight against PBS. The homo-
geneity of the preparation was assessed by SDS-PAGE, N-
terminal sequencing and mass spectrometry. The concen-
tration of the purified propeptidewas determined from the
A280 value, using the calculated extinction coefficient value
of 3840 M−1 cm−1, and confirmed by a bicinchoninic acid
assay (Pierce), using bovine serum albumin as standard.
Purified soluble propeptides and processed ProDer p 1
were sequenced in an Applied Biosystems Procise 492
sequencer (Applied Biosystems, Foster City, USA), based
on the Edman degradation.Inhibition of the rDer p 1 by the propeptide
The proteolytic activity of rDer p 1 was estimated in the
presence of various propeptide concentrations by follow-
ing the increase in fluorescence emission resulting from
the liberation of the 7-amino-4-methylcoumarin (AMC)
group upon hydrolysis of the substrate Boc-Gln-Ala-Arg-
AMC (Boc indicates N-t-butoxy-carbonyl; Bachem,
Budendorf, Switzerland). The measured fluorescence
intensity could be converted into product concentration,
with the help of an AMC (0–0.6 μM) standard curve.
Measurements were performed with an LS 50 B fluori-
meter (Perkin Elmer, Wellesey, MA, USA) using excitation
and emission wavelengths of 380 and 460 nm, respec-
tively. Enzymatic reactions were initiated by the addition
of active rDer p 1 (5 nM) to substrate solutions containing
various concentrations of the propeptide. In all cases, the
substrate concentration (40 or 160 μM) was below the Km
value (280 μM)26 and the propeptide concentration (20–
120 nM) was larger than the enzyme concentration. Under
these conditions, it was possible to determine the value of
the pseudo first-order rate constant (kobs) characteristic of
the complex formation and the individual kinetic rate
constants for association (kon) and dissociation (koff). All
experiments were carried out at 25 °C, between pH 9 and
pH 3, in 50 mM polybuffer containing 1 mM DTT and
1 mM EDTA using a 1-ml stirred cell. The kobs value was
estimated from the nonlinear part of the product forma-
tion (P) time-course using the Grafit software (Erithacus
Software Ltd., Horley, UK). Thus, for each propeptide
concentration, the apparent first-order rate constant (kobs)
182 pH Dependence of Der p 1 Propeptide Inhibitionwas determined by fitting the decrease of the initial rate of
the reaction (v0) to its steady-state rate (vs), according to
Eq. (1), where kobs depends on the propeptide concentra-
tion (I) according to Eq. (2) and considering Eq. (3):32




kobs ¼ koff þ kon KmKm þ ½S
 
I½  ð2Þ
KDGlobal ¼ koffkon ð3Þ
According to model 1, the overall KD (KDGlobal) value
was determined by linear regression of the first-order rate
constant (kobs) as a function of the propeptide concentra-





kobs ¼ koff 1þ ½IKmKDGlobalðKm þ ½SÞ
 
ð4Þ
The value of the initial dissociation constant (KDInit)
corresponding to the instantaneous inhibitory capacity
of the propeptide was estimated by fitting the calculated
initial rates (vi) to Eq. (5) using the corresponding values of




¼ 1þ Km½S þ
½IKm
KDInit½S ð5Þ
The value of the final dissociation constant (KDFinal) was
determined using Eq. (6), considering the calculated
values of the overall dissociation and initial dissociation:
KDGlob ¼ KDInitKDFinalKDFinal þ 1 ð6Þ
SPR (BIAcore) measurements
The interaction between the full-length propeptide and
recombinant unglycosylated rDer p 1 was analyzed by
SPR using a BIAcoreX instrument (BIAcore AB, Uppsala,
Sweden). Binding under equilibrium conditions and the
kinetics of binding were studied. Approximately 270
resonance units of full-length propeptide were immobi-
lized on a carboxymethylated dextran-coated sensor chip
CM5 (BIAcore AB) using the amine coupling chemistry
(1-Ethyl-3-(dimethylaminopropyl)-carbodiimide/N-hydro-
xysulfosuccinimide) according to the manufacturer's
instructions. The binding/regeneration cycles were per-
formed at 25 °C in Hepes buffered saline containing EDTA
and surfactant polysorbate 20 (10 mM Hepes, pH 7.4,
150 mM NaCl, 3 mM EDTA, 0.005% v/v surfactant poly-
sorbate 20). Surface regeneration was achieved by injec-
tion of 5 μl of 6 M guanidinium chloride at a flow rate of
10 μl/min. All measurements were repeated at least twice.
In equilibrium binding experiments, unglycosylated rDer
p 1 (128 nM) was incubated for 2 h (ensuring that the
equilibrium was reached) with increasing concentrations
of full-length propeptide (6 to 1500 nM), and then 100 μl of
the solution was injected on the CM5 surface coated with
the propeptide at a flow rate of 30 μl/min. The KD value
was determined using the model of “affinity in solution”from the BIAevaluation 4.1 software, which is based on
Eq. (7):







where E, Efree, I and KD are the total concentration of rDer
p 1, the concentration of unbound rDer p 1, the total
concentration of the propeptide and the dissociation
constant, respectively.
For kinetic experiments, different concentrations of
unglycosylated rDer p 1 were injected at a flow rate of
70 μl/min. At this flow rate, the mass transfer effects were
found to be negligible. Kinetic rate constant values for
association (ka) and dissociation (kd) (Table 1) were
obtained on the basis of two models: a two-state reaction
model (model 2) that assumes a conformational change or
a heterogeneous ligand model (model 3) provided with













KD ¼ 1KA ð9Þ
where I and E represent the propeptide and rDer p 1,
respectively, ka1 and kd1 are the kinetic rate constants for
association and dissociation of the initially formed
complex EI, respectively, and ka2 and kd2 are the kinetic
rate constants for interconversion between EI and EI*. KA






KA1 ¼ ka1 VKd1 V ð10Þ





KA2 ¼ ka2 VKd2 V ð12Þ
KD2 ¼ 1KA2 ð13Þ
where E, I1 and I2 represent rDer p 1 and two propeptide
conformations, respectively. The individual rate constants
ka and kd correspond to the association and dissociation of
the EI1 and EI2 complexes, respectively. KA1 and KA2 are
the equilibrium association constants for each reaction.
Fluorescence measurements
All fluorescence experiments were performed with the
help of a Perkin Elmer LS 50 B spectrofluorimeter using a
stirred cell with 1 cm of path length. Propeptide intrinsic
fluorescence and ANS-bound fluorescence emission spec-
tra were recorded at 25 °C in 50 mM polybuffer (pH 2–9)
using a scan speed of 280 nm per minute. The spectra were
measured four times and averaged. Intrinsic fluorescence
†http://www.accelrys.com
183pH Dependence of Der p 1 Propeptide Inhibitionmeasurements were performed using a protein concentra-
tion of 5 μM, with an excitation wavelength of 280 nm
and emission recorded from 285 to 400 nm. The binding
of ANS (Sigma, St. Louis, MO, USA) to the complete or
truncated propeptides was measured using an excita-
tion wavelength of 350 nm and recording emission
spectra from 400 to 600 nm. These were corrected for
the background fluorescence of free ANS. The concen-
tration of ANS (200 μM) was determined using the
value of the molar extinction coefficient of ANS at
350 nm (4950 M−1 cm−1), and the [ANS]/[Propeptide]
ratio was about 40.
The dynamic quenching of fluorescence of tyrosine
residues by acrylamide (ICN, Aurora, OH, USA) was
monitored with excitation and emission wavelengths of
280 and 305 nm, respectively, and using a 50-s integration
time. Propeptides were incubated with increasing con-
centrations of a small quencher molecule (acrylamide) to
probe the accessibility of the tyrosine residues within the
protein. The decrease of fluorescence intensity arising
from diffusive collisions between the quencher and the
fluorophore reflects the ability of the quencher to
penetrate the structure and can be viewed as an index of
protein flexibility.33 The solvent accessibility of tyrosine
residues was estimated by linear fitting of the (F0/F) ratio,
where F0 and F are the fluorescence in the absence and that
in the presence of acrylamide, respectively, according to
the modified Stern–Volmer equation shown in Eq. (14),
where KSV represents the Stern–Volmer constant for
dynamic quenching and [Q] is the concentration of the
quencher (i.e., acrylamide). The intrinsic protein fluores-
cence was corrected for the acrylamide inner filter effect
( f ), which was calculated using Eq. (15), with a molar




¼ 1þ KSV Q½  ð14Þ
f ¼ 10q½Q2 ð15Þ
CD measurements
CD spectra were recorded using a Jasco J-810 CD
spectropolarimeter (Jasco Inc., Easton, MD, USA)
equipped with a Peltier temperature controller. Far- and
near-UV CD spectra were recorded at 25 °C in 1 and
10 mm path length cells, respectively. Five scans were
averaged and corrected by baseline spectra subtraction.
All experiments were performed in 10 mM polybuffer
(pH 2–7) using propeptide final concentrations of 25 and
100 μM for the far- and near-UV CD experiments,
respectively. Spectra were acquired at a scan speed of
20 nm per minute, with a 1-nm bandwidth and a 4-s
integration time.
Computer simulation
The enzymatic experimental data were fitted on the
two-step model (model 2) using the equation set (Eqs.
(16)–(20)) within the Matlab software environment
(version 5.3, MathWorks Inc., Natick, USA). The routine
uses the lsqcurvefit function, which solves nonlinear least
squares problems. The differential equations of the model
are solved by a low-order Runge–Kutta method (ode23
function), which only needs to know the solution at the
preceding point.Because the values of the parameters slightly differ for
the initial concentrations of the inhibitor, a unique set of
values is chosen for the four parameters (the mean of the
best fittings) and the product concentration (P) is
simulated using the equation system (solved by a low-
order Runge–Kutta method) in order to calculate the value
of kobs. The software gives the concentration of the
different species versus time.
dE
dt
¼ k1  E Iþ k1  EI ð16Þ
dI
dt
¼ k1  E Iþ k1  EI ð17Þ
dEI
dt
¼ k1  E Iþ k2  EIT k1 þ k2ð Þ  EI ð18Þ
dEIT
dt
¼ k2  EI k2  EIT ð19Þ
dP
dt
¼ 0:36 kcat  E ð20Þ
where 0.36 represents the ratio of [S]/Km+[S].
Molecular modeling
The three-dimensional coordinates of the initial struc-
ture of the propeptide were taken from the crystal
structure of the complex between Der p 1 and its
propeptide19 and soaked in a 5-Å layer of water molecules.
The geometry was first optimized with a convergence
threshold of 0.02 kcal mol−1 Å−1 and then submitted to
two-dynamics simulations at 300K during 100 ps and
1.1 ns. The chosen force field was AMBER,34,35 the relative
dielectric constant was set to 1 and the program used was
Insight-Discover (Accelrys Software Inc.†) running on a
Pentium 4 3.4 GHz under Unix Debian.Acknowledgements
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